An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a ...

Investing.com -- Akari Therapeutics PLC (NASDAQ:AKTX) stock gained 7.9% in premarket trading Tuesday after the company released preclinical data showing its novel antibody-drug conjugate AKTX-101 ...

The β-glucan-specific antibodies were shown to bind the hyphae and germ tubes of C. albicans and the hyphal threads of A. fumigatus and to inhibit fungal growth, providing one potential mechanism by ...

Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show ...

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific ...

OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced ...

These agreements are designed to be a flexible financing solution to support operations while finalizing a strategic partnershipCompany is in advanced stages to finalize a strategic transaction with ...

Crimson Tide head coach Nick Saban released the team’s first and only depth chart for the upcoming season on Monday. Alabama’s first game week of 2020, ahead of the Crimson Tide’s conference-only ...

Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more patients.

CHARLOTTESVILLE, Va.--- Virginia football is back on the road this week when they face off against Duke. Everyone is waiting word on whether or not starting quarterback Chandler Morris, however, that ...